Cai Z, Stancou R, Korner M, Chouaib S. Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int J Cancer 1996; 68: 535-46.
Cai Z, Bettaieb A, El Mahdani N et al. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α mediated cytotoxicity. J Biol Chem 1997; 272: 6918-6926.
Perera P-Y, Qureshi N, Vogel SN. Paclitaxel (Taxol)-induced NF-κB translocation in murine macrophages. Infect Immun 1996; 64: 878-884.
Piret B, Piette J. Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells. Nucl Acids Res 1996; 24: 4242-4248.
Bargou RC, Emmerich F, Krappmann D et al. Constitutive nuclear Factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100: 2961-2969.
Sovak MA, Bellas RE, Kim DW, Zanievski GJ, Rogers AE, Traish AM. Aberrant Nuclear Factor-κB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997; 100: 2952-2960.
Wu M, Lee H, Bellas RE et al. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996; 15:4682-4690.
Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167-170.
Li Q, Van Antwerp D, Mercurio F, Lee K-F, Verma IM. Severe liver degeneration in mice lacking the IκB Kinase 2 gene. Science 1999; 284: 321-325.
Wang CY, Mayo MW, Baldwin AS. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 1996; 274: 784-787.
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-αB. Science 1996; 274: 787-789.
Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996; 274: 782-784.
Wang C-Y, Cusack JC, Liu R, Baldwin AS. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nature Med 1999; 5:412-417.
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-κB antiapoptosis: Induction of TRAF1 and TRAF-2 and c-IAP1 and c-IAP2 to suppress caspase 8 activation. Science 1998; 281: 1680-1683.
Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/AI is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev 1999; 13:382-387.
Jones PL, Ping D, Boss JM. Tumor necrosis factor alpha and interleukin-1 beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB. Mol Cell Biol 1997; 17: 6970-6981.
Webster GA, Perkins ND.Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 1999; 19: 3485-3495.
Grimm S, Bauer MKA, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced apoptosis. J Cell Biol 1996; 13-23.
Lin K-I, Lee S-H, Narayanan R, Baraban JM, Hardwick JM, Ratan RR. Thiol agents and bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J Biol Chem 1995; 131: 1149-1161.
Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection of aspirin and sodium salicylate through blockade of NF-κB activation. Science 1996; 274: 1383-1385.
Bentires-Alj M, Hellin A-C, Ameyar M, Chouaib S, Merville M-P, Bours V. Stable inhibition of Nuclear Factor κB in cancer cells does not increase sensitivity to cytotoxic drugs. Cancer Res 1999; 59: 811-815.
Cai Z, Körner M. Tarantino N, Chouaib S. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis. J Biol Chem 1997; 272:96-101.
Zhou G, Kuo MT. NF-κB-mediated induction of mdrlb expression by insulin in rat hepatoma cells. J Biol Chem 1997; 272: 15174-15183.
Mayo MW, Wang C-Y, Cogswell PC et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic ras. Science 1997; 278: 1812-1815.
Barnes PJ, Karin M. Nuclear Factor-κB - A pivotal transcription factor in chronic inflammatory diseases. New Engl J Med. 1997; 336: 1066-1071.